Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Agtc
AddedFeb 15, 2024
UpdatedJun 28, 2026
Agtc

Agtc

Public

AGTC: A biotech firm conducting clinical trials for AAV-based gene therapies for rare diseases.

HQ
Alachua, FL, US
Founded
1999
Overview
Compare
Fundraising
Employees
Website

AGTC, a biotechnology company, focuses on developing AAV-based gene therapies to treat rare diseases. Founded with the mission to transform lives through pioneering ocular gene therapy, AGTC is dedicated to saving and restoring vision for patients suffering from various prevalent and rare ophthalmic conditions. The company is currently conducting human clinical trials, including the VISTA trial for X-Linked Retinitis Pigmentosa, and offers no-cost genetic testing and prescreening for eligible participants.

Notable figures affiliated with AGTC include experienced scientists and researchers in the field of gene therapy. The company has garnered significant investment from leading biotech venture capital firms. Key achievements include advancing multiple gene therapy candidates into clinical trials and making substantial progress in the treatment of rare ocular diseases. AGTC's innovative approach has had a profound impact on the biotechnology landscape, offering hope to patients with previously untreatable conditions.

Agtc - Similar Companies

American Gene Technologies International logo

American Gene Technologies International

americangene.com

Apertura Gene Therapy logo

Apertura Gene Therapy

aperturagtx.com

Jaguar Gene Therapy logo

Jaguar Gene Therapy

Aavogen logo

Aavogen

aavogen.com

Regenxbio logo

Regenxbio

regenxbio.com

Atsena Therapeutics logo

Atsena Therapeutics

atsenatx.com

Opus Genetics logo

Opus Genetics

opusgtx.com

Editas Medicine logo

Editas Medicine

RainBio logo

RainBio

rainbio.us

MeiraGTx Holdings logo

MeiraGTx Holdings

meiragtx.com

Taysha Gene Therapies logo

Taysha Gene Therapies

tayshagtx.com

Lacerta Therapeutics logo

Lacerta Therapeutics

BioViva logo

BioViva

Oculogenex logo

Oculogenex

oculogenex.com

Solid Biosciences logo

Solid Biosciences

solidbio.com

Agtc - Quick Facts

Who are Agtc's competitors?

Companies similar to Agtc include American Gene Technologies International, Apertura Gene Therapy, Jaguar Gene Therapy and Aavogen.

When was Agtc founded?

Agtc was founded in 1999.

Where is Agtc's headquarters located?

Agtc's headquarters is located in Alachua, FL, US.

When was Agtc's last funding round?

Agtc's most recent funding round was for $10M (USD) in July 2022.

How much has Agtc raised to-date?

As of Jul 12, 2022, Agtc has raised a total of $195.1M (USD).

How many employees does Agtc have?

Agtc has 350 employees as of Feb 5, 2024.

Agtc - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Gene Therapy
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2836Biological Products, Except Diagnostic Substances
  • 2800Chemicals And Allied Products
  • 2830Drugs
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 20 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325414Biological Product (except Diagnostic) Manufacturing
  • 621000Ambulatory Health Care Services
  • 621300Offices of Other Health Practitioners
  • 621320Offices of Optometrists
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 8042Offices And Clinics Of Optometrists
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research